The Cooper Companies, Inc. (COO)
NASDAQ • Healthcare
Last close at October 2, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, The Cooper Companies, Inc. keeps $41 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Dec 3
in 60 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
The Cooper Companies’ fiscal third quarter of 2026 results were mixed versus expectations, with adjusted EPS of $1.15 topping the $1.12 estimate (+2.7%) even as revenue of $1.066 billion trailed the $1.098 billion estimate (-2.9%); the company reported the quarter ended July 31, 2026 on September 9, 2026. Revenue inched up 0.6% to about $1.1 billion (from $1.060 billion a year ago), while profitability markers came in at a gross margin of roughly 67% and an operating margin of about 21%, with gross profit around $711.9 million and operating income near $222.0 million. Net income surged 340.3% year over year to roughly $432.8 million (up from $98.3 million a year ago). Cash generation was pressured during the period, with negative operating cash flow of about $509.3 million. For the next period, consensus calls for EPS of $1.20 on revenue of $1.095 billion.
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (NASDAQ: COO) makes medical products for eye care and women's health, selling through healthcare settings and to patients. In FY2025, the company generated $4.1 billion in revenue. Its business sits in healthcare, centered on vision correction lenses, fertility and reproductive health products, and related diagnostic and surgical tools.
Today's Snapshot
COO closed 0.9% below yesterday's close, while its sector was flat.
Trading Volume
Below 10d avg (4.5M)
3.1M
vs S&P 500 Today
Underperforming Market
-1.65%
Updated: October 2, 2026 at 20:18 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$56.66 - $70.16Sell
- RSI (14)37.67Neutral
- Stochastic %K (14, 3, 3)87.63Sell
- MACD Level (12, 26)-3.04Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.